Brazil announced its national vaccine against dengue. It was produced by researchers from the Butantan Institute of São Paulo.
Public organizations of Brazil they announced that They managed to develop a vaccine against dengue totally national and with a average efficiency close to 79.8%. It was produced by researchers from the state Butantan Institute of San Pablothe largest public immunization factory in Latin America.
The news was released after the Ministry of Health will announce the start of vaccination against dengue for people between 10 and 14 years with a vaccine imported from a Japanese laboratory.
Dengue in Brazil: they announce the development of their national vaccine
dengue-vaccine-brazil.jpg
So far in 2024, the dengue outbreak that is Brazil already caused 15 deaths confirmed and another 147 are under investigation. Meanwhile, the government of Brasilia declared an emergency due to the disease transmitted by the Aedes aegypti mosquito.
In this framework, the Butantan Institute of São Paulo announced that until June it will seek register dengue vaccine before the National Health Surveillance Agency.
Through a statement from the Research Protection Foundation of the state of Sao Pauloreported that the vaccine developed by the Butantan Institute “was shown to be safe among volunteers with a history of previous infection as among those who had never been infected before.
In this way, they indicated that the results of the first two years of the clinical trial of phase 3, which began in February 2016 and included 16,235 participants from 13 states of Brazilare now detailed by subgroups.
The effectiveness of the dengue vaccine in Brazil
According to the study published in the journal The New England Journal of Medicinethe Butantan Institute vaccine had an efficacy of 80.1% for the age group of 2 to 6 years; 77.8% among the participants of 7 to 17 years; and of 90% among those of 18 to 59 years old.
According to the director of the Butantan institute, the infectologist Esper Kallásthe publication of the article in the world’s leading medical journal “attests to the rigor and quality of the work carried out by researchers from 16 Brazilian centers, located in the five regions of the country”
Source: Ambito
